Pfizer-BioNTech Shot Stops Covid’s Spread of Israeli Study Shows

Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and reviews.

Pfizer Inc. and The BioNTech SE Covid-19 vaccine appears to stop the vast majority of Israel’s beneficiaries from becoming infected, giving the first real-world indication that immunization will reduce coronavirus transmission.

The vaccine, which was launched in a national immunization program that began Dec. 20, was 89.4% effective in preventing laboratory-confirmed infections, according to a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the job. The companies and the Israeli Ministry of Health worked together on the preliminary observational analysis, which has not yet been evaluated by colleagues.

The results, also reported in Der Spiegel, are the last of a series of Positive data will emerge from Israel, which gave more Covid vaccines per capita than anywhere else in the world. Almost half of the population had at least one dose of vaccine. Separately, Israeli authorities said on Saturday that the Pfizer-BioNTech shooting was 99% effective prevention of deaths caused by the virus.

More than 202 million photos given: Covid-19 Tracker

.Source